Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Plasma Cell Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01085058
What this trial is testing

Predictive Value of the "Cytocapacity Test" Patients With Lymphoproliferative Diseases and High-dose Therapy

Who this might be right for
Hodgkin's DiseaseNon-Hodgkin LymphomasMultiple Myelomas
WiSP Wissenschaftlicher Service Pharma GmbH 169
Not applicableLooking for participantsNCT05837884
What this trial is testing

Predicting Progression of Developing Myeloma in a High-Risk Screened Population and General Population

Who this might be right for
Healthy
Tel-Aviv Sourasky Medical Center 2,000
Not applicableLooking for participantsNCT06745687
What this trial is testing

BCMA/CD3 BsAb in the Treatment of High-risk Smoldering Multiple Myeloma

Who this might be right for
High Risk Smoldering Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Study completedNCT01858558
What this trial is testing

Tadalafil and Lenalidomide Maintenance With or Without Activated Marrow Infiltrating Lymphocytes (MILs) in High Risk Myeloma

Who this might be right for
Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 102
Early research (Phase 1)Study completedNCT05320809
What this trial is testing

Study of 3D189 in Patients With Hematologic Malignancies

Who this might be right for
Acute LeukemiaMultiple MyelomaNon-Hodgkin Lymphoma+1 more
3D Medicines 16
Large-scale testing (Phase 3)Study completedNCT00461747
What this trial is testing

GEM05 for Patients With Multiple Myeloma Under 65 Years

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 390
Testing effectiveness (Phase 2)Study completedNCT01177735
What this trial is testing

Pomalidomide in Gene Expression Profiling (GEP)-Defined High-risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 71
Testing effectiveness (Phase 2)Looking for participantsNCT05828511
What this trial is testing

A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

Who this might be right for
Multiple Myeloma
Regeneron Pharmaceuticals 149
Testing effectiveness (Phase 2)UnknownNCT00004903
What this trial is testing

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Robert H. Lurie Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03455972
What this trial is testing

Study of T Cells Targeting CD19/BCMA (CART-19/BCMA) for High Risk Multiple Myeloma Followed With Auto-HSCT

Who this might be right for
Safety and Efficacy
The First Affiliated Hospital of Soochow University 43
Very early researchLooking for participantsNCT06407947
What this trial is testing

Study of CT071 Injection in High Risk Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Shanghai Changzheng Hospital 10
Testing effectiveness (Phase 2)Study completedNCT03601078
What this trial is testing

An Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma and in Subjects With High-Risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 312
Not applicableStudy completedNCT00716911
What this trial is testing

Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 100
Not applicableEnded earlyNCT00602147
What this trial is testing

Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose Melphalan

Who this might be right for
MucositisMultiple Myeloma and Plasma Cell Neoplasm
Vanderbilt-Ingram Cancer Center 95
Not applicableActive Not RecruitingNCT00039676
What this trial is testing

Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer

Who this might be right for
Waldenstrom MacroglobulinemiaChronic Lymphocytic LeukemiaHodgkin Disease+2 more
National Cancer Institute (NCI) 1,836
Early research (Phase 1)WithdrawnNCT03506802
What this trial is testing

TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple Myeloma

Who this might be right for
HLA-A*0201 Positive Cells PresentNY-ESO-1 Positive Tumor Cells PresentRecurrent Plasma Cell Myeloma+1 more
Jonsson Comprehensive Cancer Center
Early research (Phase 1)WithdrawnNCT00521261
What this trial is testing

Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Barbara Ann Karmanos Cancer Institute
Large-scale testing (Phase 3)Ended earlyNCT02489500
What this trial is testing

Trial of High Dose Melphalan/Stem Cell Transplant With or Without Bortezomib

Who this might be right for
AL Amyloidosis
Boston Medical Center 3
Testing effectiveness (Phase 2)Study completedNCT02237261
What this trial is testing

Bendamustine, Prednisone and Velcade® for First-line Treatment of Patients With Symptomatic Multiple Myeloma

Who this might be right for
Multiple Myeloma
University Hospital Heidelberg 46
Not applicableEnded earlyNCT02715102
What this trial is testing

Circulating Tumor DNA in Patients at High Risk for Lung Cancer

Who this might be right for
Cancer of the LungLung CancerLung Neoplasms+3 more
Pathway Genomics 39
Next Page